4893 items matching your search terms.

Patient-reported outcome measures for life participation in peritoneal dialysis: a systematic review

Manera, K. E. Ju, A. Baumgart, A. Hannan, E. Qiao, W. Howell, M. Nataatmadja, M. Wilkie, M. Loud, F. Schwartz, D. Hurst, H. Jassal, S. V. Figueiredo, A. Mehrotra, R. Shen, J. Morton, R. L. Moraes, T. Walker, R. Cheung, C. Farragher, J. F. Craig, J. Johnson, D. W. Tong, A.
NEPHROLOGY, DIALYSIS, TRANSPLANTATION, 2020     DOI:10.1093/ndt/gfaa244

Back-projection of COVID-19 diagnosis counts to assess infection incidence and control measures: analysis of Australian data

Marschner, I. C.
EPIDEMIOLOGY AND INFECTION, 2020     DOI:10.1017/S0950268820001065

Sensitivity analyses assessing the impact of early stopping on systematic reviews: Recommendations for interpreting guidelines

Marschner, I. C. Askie, L. M. Schou, I. M.
RES SYNTH METHODS, 2020     DOI:10.1002/jrsm.1394

The effect of PCSK9 inhibition on the risk of venous thromboembolism

Marston, N. A. Gurmu, Y. Melloni, G. E. M. Bonaca, M. Gencer, B. Sever, P. S. Pedersen, T. R. Keech, A. C. Roselli, C. Lubitz, S. A. Ellinor, P. T. O'Donoghue, M. L. Giugliano, R. P. Ruff, C. T. Sabatine, M. S.
CIRCULATION, 2020     DOI:10.1161/CIRCULATIONAHA.120.046397

Predicting benefit from evolocumab therapy in patients with atherosclerotic disease using a genetic risk score: Results from the FOURIER trial

Marston, N. A. Kamanu, F. K. Nordio, F. Gurmu, Y. Roselli, C. Sever, P. S. Pedersen, T. R. Keech, A. C. Wang, H. Lira Pineda, A. Giugliano, R. P. Lubitz, S. A. Ellinor, P. T. Sabatine, M. S. Ruff, C. T.
CIRCULATION, 2020     DOI:10.1161/CIRCULATIONAHA.119.043805

Clinical trials with cannabis medicines-guidance for ethics committees, governance officers and researchers to streamline ethics applications and ensuring patient safety: considerations from the Australian experience

Martin, J. H. Hill, C. Walsh, A. Efron, D. Taylor, K. Kennedy, M. Galettis, R. Lightfoot, P. Hanson, J. Irving, H. Agar, M. Lacey, J.
TRIALS, 2020     DOI:10.1186/s13063-020-04862-6

Six months of hybrid closed-loop versus manual insulin delivery with fingerprick blood glucose monitoring in adults with type 1 diabetes: A randomized, controlled trial

McAuley, S. A. Lee, M. H. Paldus, B. Vogrin, S. de Bock, M. I. Abraham, M. B. Bach, L. A. Burt, M. G. Cohen, N. D. Colman, P. G. Davis, E. A. Hendrieckx, C. Holmes-Walker, D. J. Kaye, J. Keech, A. C. Kumareswaran, K. MacIsaac, R. J. McCallum, R. W. Sims, C. M. Speight, J. Stranks, S. N. Sundararajan, V. Trawley, S. Ward, G. M. Jenkins, A. J. Jones, T. W. O'Neal, D. N. Australian, Jdrf Closed-Loop Research Group
DIABETES CARE, 2020     DOI:10.2337/dc20-1447

NUC-1031/cisplatin versus gemcitabine/cisplatin in untreated locally advanced/metastatic biliary tract cancer (NuTide:121)

McNamara, M. G. Goyal, L. Doherty, M. Springfeld, C. Cosgrove, D. Sjoquist, K. M. Park, J. O. Verdaguer, H. Braconi, C. Ross, P. J. Gramont, A. Zalcberg, J. R. Palmer, D. H. Valle, J. W. Knox, J. J.
FUTURE ONCOLOGY, 2020     DOI:10.2217/fon-2020-0247

Cost-effectiveness of dementia care mapping in care-home settings: Evaluation of a randomised controlled trial

Meads, D. M. Martin, A. Griffiths, A. Kelley, R. Creese, B. Robinson, L. McDermid, J. Walwyn, R. Ballard, C. Surr, C. A.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2020     DOI:10.1007/s40258-019-00531-1

Patient-reported outcomes and localized prostate cancer management

Mercieca-Bebber, R. Stockler, M. R.
NAT REV UROL, 2020     DOI:10.1038/s41585-020-0303-2

Use of patient-reported outcome measures and patient-reported experience measures in renal units in Australia and New Zealand: A cross-sectional survey study

Morton, R. L. Lioufas, N. Dansie, K. Palmer, S. C. Jose, M. D. Raj, R. Salmon, A. Sypek, M. Tong, A. Ludlow, M. Boudville, N. McDonald, S.
NEPHROLOGY (CARLTON), 2020     DOI:10.1111/nep.13577

Evidence-based follow-up schedules after primary cancer treatment

Morton, R. L. Thompson, J. F.
ANNALS OF SURGICAL ONCOLOGY, 2020     DOI:10.1245/s10434-020-08768-0

The relationship between latitude and allergic gastroenteritis hospital admissions in New Zealand infants

Mullins, R. J. Campbell, D. E. Barnes, E. H. Camargo, C. A., Jr.
ANNALS OF ALLERGY, ASTHMA, AND IMMUNOLOGY, 2020     DOI:10.1016/j.anai.2019.10.004

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial

Murray Brunt, A. Haviland, J. S. Wheatley, D. A. Sydenham, M. A. Alhasso, A. Bloomfield, D. J. Chan, C. Churn, M. Cleator, S. Coles, C. E. Goodman, A. Harnett, A. Hopwood, P. Kirby, A. M. Kirwan, C. C. Morris, C. Nabi, Z. Sawyer, E. Somaiah, N. Stones, L. Syndikus, I. Bliss, J. M. Yarnold, J. R. F. AST-Forward Trial Management Group
LANCET, 2020     DOI:10.1016/S0140-6736(20)30932-6

Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis

Nassar, Z. D. Mah, C. Y. Dehairs, J. Burvenich, I. J. Irani, S. Centenera, M. M. Helm, M. Shrestha, R. K. Moldovan, M. Don, A. S. Holst, J. Scott, A. M. Horvath, L. G. Lynn, D. J. Selth, L. A. Hoy, A. J. Swinnen, J. V. Butler, L. M.
ELIFE, 2020     DOI:10.7554/eLife.54166